Long Term Management of Stroke Patients with Drug Associated Problems
DOI:
https://doi.org/10.26452/fjphs.v3i3.479Keywords:
Assessment, Complications, Treatment modulation, Neurological impairAbstract
A focused neurological impairment with a quick onset and a duration of more than 24 hours is referred to as a stroke. Transient ischemia attack, which is described as a focused neurological symptom lasting less than 24 hours, is not included in this classification. Identifies the complication of the patient and how those complications are addressed. A complication is an adverse event that occurs due to a medical treatment or surgical procedure. It is a form of therapy strategy utilised to improve outcome of the therapy for a disease or condition. An anticipated observational study carried out within the division of neurology as well as neurosurgery for a period of 6 months. The study was conducted by collecting information from patients suffering with stroke by using a patient consent form. It was a prospective observational study carried out in the department of neurology and Neurosurgery for 6 months. The total number of participants in the research we conducted were 150 out of which male patients were 93(60%)and females were 57(38%) are less likely present, the age group of the people carried out in our study were maximum between >66 that is 39 (24.4%) and minimum between 30-40 that is 10 (6.2%), all are suffering with stroke and the data is obtained and discussed. Our research showed that the majority of the patients having difficulty with different types of stroke was taken into consideration with their treatment modulations and assessment of their outcomes. Most of the people were recovered from the condition out of which it analyses the effects to make the life better; our study also estimates the complications and treatment to have a better therapeutic outcome.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Future Journal of Pharmaceuticals and Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.